ReviewLeukemia & lymphoma2018
Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.
Ayed O Ayed et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it